Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

ClinicalTrials.gov ID: NCT01157364

Public ClinicalTrials.gov record NCT01157364. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label (Stage 1) and Randomized (Stage 2), 24 Month Study of Safety and Efficacy of Bimatoprost Drug Delivery System in Patients With Open-Angle Glaucoma or Ocular Hypertension

Study identification

NCT ID
NCT01157364
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Allergan
Industry
Enrollment
109 participants

Conditions and interventions

Interventions

  • bimatoprost 20 µg generation 2 Drug
  • bimatoprost 15 µg generation 2 Drug
  • bimatoprost 10 µg generation 2 Drug
  • bimatoprost 6 µg generation 2 Drug
  • bimatoprost 15 µg generation 1 Drug
  • bimatoprost 10 µg generation 1 Drug
  • bimatoprost 0.03% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2010
Primary completion
Jul 26, 2016
Completion
Aug 8, 2016
Last update posted
Mar 29, 2020

2010 – 2016

United States locations

U.S. sites
36
U.S. states
16
U.S. cities
34
Facility City State ZIP Site status
Sall Research Medical Center Artesia California 90701
Shiley Eye Center, Hamilton Glaucoma Center, University of California, San Diego La Jolla California 92093
Doheny Eye Institute Los Angeles California 90033
Martel Eye Medical Group Rancho Cordova California 95670
Shasta Eye Medical Group, Inc. Redding California 96002
Grutzmacher and Lewis, Inc. Sacramento California 95815
Pacific Eye Surgeons San Luis Obispo California 93401
Wolstan & Goldberg Eye Associates Torrance California 90505
Specialty Eye Care Parker Colorado 80134
The Eye Associates of Manatee Bradenton Florida 34209
Emory University, The Emory Eye Center Atlanta Georgia 30322
Coastal Research Associates Roswell Georgia 30076
Springfield Clinic Springfield Illinois 62703
Glaucoma Consultants Baltimore Maryland 21204
Tufts Medical Center/New England Eye Center Boston Massachusetts 02111
Ophthalmic Consultants of Boston Boston Massachusetts 02114
ActivMed Practices & Research Methuen Massachusetts 01844
Clinical Eye Research of Boston/ Charles River Eye Associates Winchester Massachusetts 01890
Moyes Eye Center Kansas City Missouri 64154
Northern New Jersey Eye Institute PA South Orange New Jersey 07079
Ophthalmic Consultants of Long Island Lynbrook New York 11563
Glaucoma Associates of NY New York New York 10003
Rochester Ophthalmological Group PC Rochester New York 14618
Charlotte Eye Ear Nose & Throat Associates, PA Charlotte North Carolina 28210
Cornerstone Eye Care High Point North Carolina 27262
James D. Branch, MD Winston-Salem North Carolina 27101
Legacy Good Samaritan - Devers Eye Institute Portland Oregon 97210
Scott & Christie and Associates Cranberry Township Pennsylvania 16066
Philadelphia Eye Associates Philadelphia Pennsylvania 19148
Keystone Research LTD Austin Texas 78731
Glaucoma Associates of TX Dallas Texas 75231
R and R Eye Research San Antonio Texas 78229
Medical Center Ophthalmology Associates San Antonio Texas 78240
Focus Clinical Research Salt Lake City Utah 84107
Spokane Eye Clinical Research Spokane Washington 99204
Wenatchee Valley Medical Center Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01157364, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01157364 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →